Position in EVMN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$26,369
New position
Shares Held
1,147
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Plante Moran Financial Advisors, LLC holds $461,659 across 15 Biotechnology names. EVMN ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
635 | $210,102 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
10,836 | $107,818 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
169 | $75,465 | |
| 4 | EVMN |
Evommune, Inc.
This page
|
1,147 | $26,369 | |
| 5 | SABS |
SAB Biotherapeutics, Inc.
|
5,925 | $22,692 | |
| 6 | OMER |
Omeros Corp
|
1,000 | $10,560 | |
| 7 | BHVN |
Biohaven Ltd.
|
362 | $3,062 | |
| 8 | ARGX |
Argenx SE
|
4 | $2,921 |
All Filings in EVMN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,369 | 1,147 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||